Coupling CD28 Co-stimulation to immunoglobulin T-cell receptor molecules: The dynamics of t-cell proliferation and death

Journal of Immunotherapy

Volumn 23, Issue 6, 2000, Pages 631-642

  Beecham, E J ^a   Ma, Q ^a   Ripley, R ^a   Junghans, R P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Activation; CD28; Clonal selection; Immunoglobulin T cell receptor; Proliferation

Indexed keywords

AUTOANTIGEN; CD28 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; T LYMPHOCYTE RECEPTOR;

ARTICLE; CANCER IMMUNOTHERAPY; CELL DEATH; CELL DIVISION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE RELEASE; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIBODY AFFINITY; ANTIGENS, CD28; CARCINOEMBRYONIC ANTIGEN; CELL DEATH; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0033677159     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200011000-00004     Document Type: Article

References (41)

1. Expression of chimeric receptor composed of immunoglobulin-derived V regions and T cell receptor derived C regions
2. Expression of immunoglobulin-T-cells receptor chimeric molecules as functional receptors with antibody-type specificity
3. Chimeric immunoglobulin-T cell receptor proteins form functional receptors: Implications for T cell receptor complex formation and activation
4. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides
5. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors
6. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor γ chain
7. Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors
8. Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice
9. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells
10. Single chain Ig/γ gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity
11. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes
12. Lysis of HIV-I-infected cells and inhibition of viral replication by universal receptor T cells
13. An anti-CD30 chimeric receptor that mediates CD3-ζ-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30
14. In vivo antitumor activity of T-cells redirected with chimeric antibody/T-cell receptor genes
15. Dynamics of tumor cell killing by human T lymphocytes armed with an anti-CEA chimeric immunoglobulin T cell receptor
16. Bypassing immunization: Optimized design of 'designer T cells' against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA
17. The complexities of T cell costimulation: CD28 and beyond
18. The role of B7-1/B7-2:CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and downregulation of immune response
19. Absence of B7-dependent responses in CD28-deficient mice
20. Naive Cd28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response
21. Purified MHC class I peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/Icam-1 costimulatiory interactions
22. Requirements for stimulating naive CD8 T cells via signal one alone
23. Qualitative and Quantitative effects of CD28/B7-mediated costimulation on naive T cell in vitro
24. Isolation and characterization of an undifferentiated human colon cancer cell line (MIP-101)
25. The effect of transfection of the CEA gene in the metastatic behavior of the human colorectal cancer cell line MIP-101
26. Cd28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation
27. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma
28. Scintigraphy with indium-111 labeled lymphokine-activated killer cells of malignant brain tumor
29. Imaging pattern of radiolabeled lymphokine activated killer cells in patients with metastatic malignant melanoma
30. In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2
31. A triad of costimulatory molecules synergize to amplify T cell activation
32. Stimulating naive T cells
33. Cancer patients T cells genetically targeted to prostate-specific membrane antigen specificially lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen
34. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28
35. CD28 delivers a costimulatory signal involved in antigen specific IL2 production by human T cells
36. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway
37. Antigen-specific development of primary and memory T cells in vivo
38. Functional maturation of and antiviral cytotoxic T cell response
39. Evolution of a complex TCR repertoire during primary and recall bacterial infection
40. T cell affinity maturation by selective expansion during infection